Ubrogepant
Ubrogepant, also known as MK-1602, is a potent and selective oral calcitonin gene-related peptide (CGRP) receptor antagonist.
| Catalog Number | 10-101-185 |
| Alternative Name(s) | MK-1602, MK 1602, MK1602 |
| Research Area | Ubrogepant is investigated for acute treatment of migraines. |
| Molecular Formula | C29H26F3N5O3 |
| CAS# | 1374248-77-7 |
| Purity | >98% |
| Inchi | InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1 |
| Inchi Key | DDOOFTLHJSMHLN-ZQHRPCGSSA-N |
| SMILES | C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6 |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/ubrogepant-item-10-101-185-33670.html |